We are live on ! Find out more
EVH icon

Evolent Health
EVH

80 hedge funds and large institutions have $347M invested in Evolent Health in 2016 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 33 increasing their positions, 13 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

154% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 13

100% more capital invested

Capital invested by funds: $173M → $347M (+$174M)

92% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 12

14% more funds holding

Funds holding: 70 → 80 (+10)

3.74% more ownership

Funds ownership: 38.69% → 42.43% (+3.7%)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $10K

Holders
80
Holders Change
+10
Holders Change %
+14.29%
% of All Funds
2.13%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
23
Increased
33
Reduced
13
Closed
12
Calls
–
Puts
$10K
Net Calls
-$10K
Net Calls Change
-$10K

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$3.49M
2
CC
Casdin Capital
New York
+$3.29M
3
William Blair & Company
William Blair & Company
Illinois
+$3.16M
4
Macquarie Group
Macquarie Group
Australia
+$2.89M
5
EI
EAM Investors
California
+$2.84M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$4.74M
2
PC
Pier Capital
Connecticut
-$3.47M
3
Renaissance Technologies
Renaissance Technologies
New York
-$2.74M
4
ECP
Elk Creek Partners
Colorado
-$1.34M
5
TCM
TimesSquare Capital Management
New York
-$1.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
CG
76
Cutler Group
California
$5K -$12.2K -891 -75%
Bank of Montreal
77
Bank of Montreal
Ontario, Canada
$3K +$1.96K +143 New
Citigroup
78
Citigroup
New York
$2K -$126K -9,175 -99%
MTIP
79
Magee Thomson Investment Partners
California
$2K +$1.17K +85 New
QI
80
QS Investors
New York
$1K +$302 +22 New
PC
81
Pier Capital
Connecticut
– -$3.47M -328,519 Closed
Renaissance Technologies
82
Renaissance Technologies
New York
– -$2.74M -259,100 Closed
MAG
83
Millrace Asset Group
Pennsylvania
– -$817K -77,400 Closed
Brown Advisory
84
Brown Advisory
Maryland
– -$528K -50,000 Closed
Norges Bank
85
Norges Bank
Norway
– -$422K -40,000 Closed
EMG
86
Ellington Management Group
Connecticut
– -$408K -38,600 Closed
Citadel Advisors
87
Citadel Advisors
Florida
– -$166K -15,676 Closed
Susquehanna International Group
88
Susquehanna International Group
Pennsylvania
– -$118K -11,213 Closed
DTL
89
Dynamic Technology Lab
Singapore
– -$112K -10,555 Closed
SO
90
STRS Ohio
Ohio
– -$81K -7,700 Closed
TRCT
91
Tower Research Capital (TRC)
New York
– -$45K -4,256 Closed
Group One Trading
92
Group One Trading
Illinois
– -$11K -800 Closed
1 2 3
4

EVH Hedge Fund Activity: Q2 2016 in Review

80 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q2 2016, worth a combined $347M — up 100% from $173M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new EVH positions and 12 closed out — a net gain of 11 holders — while 33 added to existing stakes and 13 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $3.49M. The largest seller was Goldman Sachs, cutting an estimated $4.74M.

  • 80 institutional investors held Evolent Health (EVH) as of Q2 2016, up from 70 in Q1 2016.
  • Funds reported $347M of Evolent Health stock for Q2 2016, up 100% quarter-over-quarter.
  • 23 funds opened new Evolent Health positions in Q2 2016 and 12 closed out, a net change of +11 holders.
  • The largest Evolent Health buyer in Q2 2016 was Perceptive Advisors, an estimated $3.49M added.
  • The largest Evolent Health seller in Q2 2016 was Goldman Sachs, an estimated $4.74M sold.

Based on aggregated 13F filings for Q2 2016.